1 BlackRock Definium Therapeutics Trades
BlackRock acquired 8.48M Definium Therapeutics shares worth $209M. That's 0.00% of their equity portfolio (1648th largest holding). The investor owns 7.90% of the outstanding Definium Therapeutics stock.
News about Definium Therapeutics, Inc. and BlackRock
Mind Medicine to join Russell 2000 index
No summary available.
Mind Medicine CEO Robert Barrow sells shares worth over $113k
https://www.investing.com/news/company-news/mind-medicine-ceo-robert-barrow-sells-shares-worth-over-113k-93CH-3496705
MindMed Advances GAD Treatment into Phase 3 Trials
Mind Medicine (MNMD) has released an update. Mind Medicine (MindMed) Inc. has successfully concluded an End-of-Phase 2 meeting with the FDA, paving…
Mind Medicine Inc.: MindMed to Present at the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference
Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (the "Company" or "MindMed"), a clinical stage biopharmaceutical company developing novel product candidates to t...